Unknown

Dataset Information

0

A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer.


ABSTRACT:

Background

This study compared the efficacy/safety of the camptothecin analogues belotecan and topotecan for sensitive-relapsed small-cell lung cancer (SCLC).

Methods

One-hundred-and-sixty-four patients were randomised (1:1) to receive five consecutive daily intravenous infusions of topotecan (1.5 mg/m2) or belotecan (0.5 mg/m2), every 3 weeks, for six cycles. Main outcomes were objective response rate (ORR), disease control rate (DCR), progression-free survival (PFS), overall survival (OS), tolerability and toxicity. The study statistical plan was non-inferiority design with ORR as the endpoint.

Results

In the belotecan vs. topotecan groups, ORR (primary endpoint) was 33% vs. 21% (p = 0.09) and DCR was 85% vs. 70% (p = 0.030). PFS was not different between groups. Median OS was significantly longer with belotecan than with topotecan (13.2 vs. 8.2 months, HR = 0.69, 95% CI: 0.48-0.99), particularly in patients aged <65 years, with more advanced disease (i.e., extensive-stage disease, time to relapse: 3-6 months), or Eastern Cooperative Oncology Group performance status 1 or 2. More belotecan recipients completed all treatment cycles (53% vs. 35%; p = 0.022).

Conclusions

The efficacy/safety of belotecan warrants further evaluation in Phase 3 trials. Belotecan potentially offers an alternative to topotecan for sensitive-relapsed SCLC, particularly in patients aged <65 years, with more advanced disease, or poor performance.

SUBMITTER: Kang JH 

PROVIDER: S-EPMC7884704 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7853132 | biostudies-literature
| S-EPMC3407653 | biostudies-other
| S-EPMC7099331 | biostudies-literature
| S-EPMC6085992 | biostudies-literature
| S-EPMC2931489 | biostudies-literature
| S-EPMC7734004 | biostudies-literature
| S-EPMC5710232 | biostudies-literature
| S-EPMC8674688 | biostudies-literature
| S-EPMC4614251 | biostudies-other
| S-EPMC4207330 | biostudies-other